Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005 Mar 11;120(5):701-13. PubMed Abstract

  
Comments on Paper and Primary News
  Primary News: Sorrento: More Fun, Less Amyloid for Transgenic Mice

Comment by:  Joanna Jankowsky
Submitted 18 March 2005  |  Permalink Posted 18 March 2005

The main point of commonality between our work on environmental enrichment and plaque deposition (Jankowsky et al., 2003) and that of Lazarov et al. is the demonstration that environment can substantially influence the level of amyloid and Aβ peptide in the brain, even in mice carrying a variant APP allele that is associated with autosomal-dominant AD. Collectively, these studies provide experimental evidence for many decades of epidemiological studies suggesting that non-genetic factors such as education, occupation, and lifestyle can influence the risk for developing dementia.

That our work and that of Lazarov et al. reach different outcomes as to the effect of environment on Aβ levels indicates to us that a lot of interesting biology remains yet to be discovered about how the production and/or clearance of Aβ is regulated in response to diverse forms of enriched housing.

Significant differences between the two studies include the gender of the mice and the design of the enriched setting in...  Read more


  Primary News: Sorrento: More Fun, Less Amyloid for Transgenic Mice

Comment by:  Gary Arendash
Submitted 18 March 2005  |  Permalink Posted 18 March 2005

The informative paper by Lazarov and colleagues is a logical extension of our earlier study, wherein we showed that environmental enrichment to "aged" APPsw transgenic mice provides global cognitive improvement without reducing their already well-established brain Aβ deposition (Arendash et al., 2004). Although our study indicates that mechanisms independent of Aβ deposition are sufficient for behavioral benefit in “aged” AD transgenic mice, the Lazarov study shows that environmental enrichment begun at an early age has the capacity to reduce developing brain Aβ levels/deposition, perhaps in part through the elevated neprilysin activity they also report. It should be noted that the study was conducted only with male mice, so the extend to which the findings hold for females is an open question, especially in view of another study (Jankowsky et al., 2003) showing that a different enrichment protocol actually increases Ab deposition in female AD transgenic mice.

The authors present data showing that transgenic mice having higher physical (wheel-running) activity during the...  Read more


  Primary News: Sorrento: More Fun, Less Amyloid for Transgenic Mice

Comment by:  Sangram Sisodia
Submitted 21 March 2005  |  Permalink Posted 21 March 2005

Reply by Sangram Sisodia and Orly Lazarov
The cage-mates in our study were all littermates; therefore three to four animals shared a cage in our enrichment experiment. I agree that much more needs to be done to validate the model and the outcomes.

View all comments by Sangram Sisodia
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Studied mice co-expressing APPSw/PS1DE9 with and without an enrichment environment. For Western blotting or immunohistochemistry, the following antibodies were used: CT15, mAb22C11, mouse anti-a-tubulin (Sigma 1:1,000,000), anti-Ab mAb3D6 (1:2,500), anti-Aβ40 mAb2G3 (1:2,500), Cy5- or Cy3-conjugated donkey anti-mouse IgG (1:250).

Cerebral Ab was detected using ELISA protocols, Ab was captured with either JRF/cAb40/10 or JRF/cAb42/26, monoclonal antibodies specific for Ab40 and Ab42, respectively, supplied by Dr. M. Mercken (Janssen Research Foundation, Beerse, Belgium). Captured peptides were reported with horseradish peroxidase-conjugated m266, a monoclonal antibody recognizing residues 13–28 of Ab.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad